Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $3,144 - $3,675
98 Added 1.65%
6,040 $200,000
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $108 - $125
3 Added 0.05%
5,942 $217,000
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $196 - $256
-5 Reduced 0.08%
5,939 $242,000
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $7,306 - $9,537
175 Added 3.03%
5,944 $0
Q3 2022

Nov 02, 2022

BUY
$43.76 - $53.42 $43,847 - $53,526
1,002 Added 21.02%
5,769 $252,000
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $11,679 - $13,847
251 Added 5.56%
4,767 $250,000
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $18,254 - $22,619
-399 Reduced 8.12%
4,516 $234,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $4,875 - $7,227
118 Added 2.46%
4,915 $290,000
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $188,282 - $241,864
4,797 New
4,797 $206,000
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $160,774 - $229,711
-5,948 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $4,970 - $5,641
151 Added 2.6%
5,948 $233,000
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $9,941 - $12,891
306 Added 5.57%
5,797 $208,000
Q2 2019

Jul 31, 2019

SELL
$36.98 - $41.52 $70,631 - $79,303
-1,910 Reduced 25.81%
5,491 $238,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $60,225 - $66,167
-1,606 Reduced 17.83%
7,401 $308,000
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $269 - $307
7 Added 0.08%
9,007 $393,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $310,230 - $376,290
9,000 New
9,000 $397,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track J. L. Bainbridge & Co., Inc. Portfolio

Follow J. L. Bainbridge & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.